Abenex Continuation Fund Acquires Majority Stake in Europa Group; Europa Acquires APM International
April 29, 2024
Abenex closed an oversubscribed continuation fund (~€300m) to acquire a majority stake in Europa Group from its Abenex V portfolio, making Abenex the group's majority shareholder while founders remain significant owners and management continues. As part of its buy-and-build strategy supported by the recapitalization, Europa Group also acquired APM International (a France-based healthcare press agency) to strengthen its medical information and publishing capabilities.
- Buyers
- Abenex
- Targets
- Europa Group, APM International
- Sellers
- Abenex V, Wilmington plc
- Platforms
- Europa Group
- Industry
- Healthcare Services
- Location
- France
- Transaction Type
- Recapitalization
Explore More
Related Acquisitions
-
Abenex Invests in Groupe ESCG to Accelerate Expansion
January 6, 2022
Education
French private equity firm Abenex has made a minority growth investment in Groupe ESCG, becoming a reference shareholder to support the school's development alongside founder Gilles Samama. The investment will fund geographic expansion — including planned new campuses in Lyon and Marseille — and operational support to scale ESCG's work-study accounting training programs.
-
Apax Partners and Fremman Capital acquire co-controlling stakes in Palex Medical
August 1, 2023
Medical Devices
Funds advised by Apax Partners LLP and funds advised by Fremman Capital agreed to acquire co-controlling stakes in Palex Medical, with Fremman remaining an investor while some of its funds and other minority shareholders sell. Palex, a Sant Cugat del Vallès (Barcelona)-headquartered MedTech distributor with ~928 employees, will partner with Apax and Fremman to accelerate pan-European growth and international expansion; the deal is expected to close in Q4 2023 and financial terms were not disclosed.
-
Abenex Takes Minority Stake in Phenomen
September 6, 2023
Insurance
Abenex, a European private equity firm, has acquired a minority stake in Phenomen, a Paris-based insurtech specializing in contingency, embedded and event cancellation insurance. The investment will support Phenomen's operational and financial strengthening, accelerate its rollout across Europe, and enable transformative M&A to scale its Meetch (embedded insurance) and Leeloo (event cancellation) businesses.
-
Bain Capital Acquires Apleona from PAI Partners
February 14, 2025
Real Estate
Bain Capital, through a consortium led by its Europe Private Equity team, has agreed to acquire Apleona, the Neu-Isenburg-based European integrated facility management group, from PAI Partners. The deal will support Apleona's continued growth — including European platform expansion, digital transformation and ESG/decarbonisation capabilities — and is subject to customary closing conditions and regulatory approvals.
-
Abenex Invests in EDL (Edition et Développement Logiciels) to Accelerate Growth
May 11, 2021
Software
Abenex has become a new shareholder in EDL (Edition et Développement Logiciels), the French developer of Xplore, a RIS/PACS and medical-imaging software suite, to support the company’s development, governance structuring and international expansion. The investment will back EDL’s organic growth and targeted acquisitions while facilitating a leadership transition as one founder steps back from operational duties.
-
Apax Acquires Majority Stake in CEME Group
March 17, 2022
HVAC & Mechanical
Apax (with Société Générale Capital Partenaires and BNP Paribas Développement) has signed an agreement to acquire a majority stake in CEME Group, a French leader in electrical and HVAC engineering and maintenance. The transaction (subject to competition approval) reorganises shareholding to exit Azulis Capital and the Desbruères family and aims to accelerate organic growth and M&A to expand regional presence and capabilities in energy efficiency and related services.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.